![aRCC: 1L Treatment Options and Patient Management](http://media.vumedi.com/thumbs/channel_logo/2022/9/60735544-fe62-43a8-921f-e700719e64d6.png.200x0_q85.png)
aRCC: 1L Treatment Options and Patient Management
ASCO GU 2022 Update on CheckMate 214 With Extended 5-Year Follow-Up: Efficacy and Safety of Nivo+Ipi vs. Sunitinib for 1L Treatment of Advanced sRCC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Scott Tykodi
By
ASCO Genitourinary Cancers Symposium
FEATURING
Scott Tykodi
182 views
March 14, 2022
Comments 0
Login to view comments.
Click here to Login